| 1 |
33273169 | Central Nervous System Lymphomas. | 2020 Dec |
1 |
| 2 |
30423172 | Introduction of novel agents in the treatment of primary CNS lymphoma. | 2019 Feb 19 |
2 |
| 3 |
25984532 | Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma. | 2015 |
1 |
| 4 |
22975686 | BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB. | 2013 Jan |
1 |
| 5 |
22698399 | Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. | 2012 Jun 12 |
1 |